XML 179 R155.htm IDEA: XBRL DOCUMENT v3.22.0.1
VALUATION AND QUALIFYING ACCOUNTS (Schedule of Valuation and Qualifying Accounts) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Accounts Receivable - Allowance for Doubtful Receivables      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of year $ 51 $ 45 $ 42
Additions charged to expenses 16 22 24
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction (13) (16) (21)
Balance at end of year 54 51 45
Accounts Receivable - Allowance for Doubtful Receivables | Sadara Chemical Company      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Additions charged to expenses 2    
Inventory - Obsolescence Reserve      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of year 23 35 23
Additions charged to expenses 3 2 19
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction (12) (14) (7)
Balance at end of year 14 23 35
Reserves for Other Investments and Noncurrent Receivables      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of year 2,093 2,215 460
Additions charged to expenses 19 7 1,758
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction (79) (129) (3)
Balance at end of year 2,033 2,093 2,215
Reserves for Other Investments and Noncurrent Receivables | Sadara Chemical Company      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Additions charged to expenses 1,753    
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction (77) (77)  
Deferred Tax Assets - Valuation Allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of year 1,302 1,262 1,225
Additions charged to expenses 201 313 140
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction (112) (273) (103)
Balance at end of year $ 1,391 $ 1,302 $ 1,262